Nutriband Inc. has announced a 25% preferred stock dividend. Shareholders of record on July 25th, 2025, will receive one preferred share for every four shares of common stock held. This marks a new dividend issuance as the company moves towards FDA approval for its AVERSA Fentanyl product.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.